Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis.

Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC 2nd, McMasters KM, Cho CS, Winslow ER, Wood WC, Staley CA 3rd.

J Am Coll Surg. 2011 Apr;212(4):638-48; discussion 648-50. doi: 10.1016/j.jamcollsurg.2011.01.004.

2.

Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.

Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF.

World J Surg. 2011 Sep;35(9):2073-82. doi: 10.1007/s00268-011-1161-0.

PMID:
21656309
3.

Preoperative total cholesterol predicts postoperative outcomes after partial hepatectomy in patients with chronic hepatitis B- or C-related hepatocellular carcinoma.

Wang Q, Lau WY, Zhang B, Zhang Z, Huang Z, Luo H, Chen X.

Surgery. 2014 Feb;155(2):263-70. doi: 10.1016/j.surg.2013.08.017. Epub 2013 Oct 25.

PMID:
24569301
4.

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, Cha S, Kamath P, Kim R, Nagorney DM.

J Gastrointest Surg. 2005 Dec;9(9):1207-15; discussion 1215.

PMID:
16332475
5.

Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.

Teh SH, Sheppard BC, Schwartz J, Orloff SL.

Am J Surg. 2008 May;195(5):697-701. doi: 10.1016/j.amjsurg.2007.05.054.

PMID:
18367132
6.

Potential role of cholinesterases to predict short-term outcome after hepatic resection for hepatocellular carcinoma.

Donadon M, Cimino M, Procopio F, Morenghi E, Montorsi M, Torzilli G.

Updates Surg. 2013 Mar;65(1):11-8. doi: 10.1007/s13304-012-0174-z. Epub 2012 Aug 22.

PMID:
22911016
7.

Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.

Lim C, Compagnon P, Sebagh M, Salloum C, Calderaro J, Luciani A, Pascal G, Laurent A, Levesque E, Maggi U, Feray C, Cherqui D, Castaing D, Azoulay D.

HPB (Oxford). 2015 Jul;17(7):611-23. doi: 10.1111/hpb.12416. Epub 2015 May 16.

8.

Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy.

Wang HQ, Yang J, Yang JY, Wang WT, Yan LN.

World J Gastroenterol. 2014 Sep 7;20(33):11871-7. doi: 10.3748/wjg.v20.i33.11871.

9.

Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.

Patel SH, Kneuertz PJ, Delgado M, Kooby DA, Staley CA 3rd, El-Rayes BF, Kauh JS, Sarmiento JM, Hanish S, Cohen C, Farris AB 3rd, Maithel SK.

Ann Surg Oncol. 2011 Nov;18(12):3384-90. doi: 10.1245/s10434-011-1775-3. Epub 2011 May 18.

PMID:
21590454
10.

Cigarette smoking increases risk of early morbidity after hepatic resection in patients with hepatocellular carcinoma.

Lv Y, Liu C, Wei T, Zhang JF, Liu XM, Zhang XF.

Eur J Surg Oncol. 2015 Apr;41(4):513-9. doi: 10.1016/j.ejso.2015.01.015. Epub 2015 Jan 26.

PMID:
25656703
11.

Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria.

Sakaguchi T, Suzuki S, Morita Y, Oishi K, Suzuki A, Fukumoto K, Inaba K, Nakamura S, Konno H.

Surg Today. 2010 Jul;40(7):638-45. doi: 10.1007/s00595-009-4109-3. Epub 2010 Jun 26.

PMID:
20582515
12.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

13.

Preoperative thrombocytopenia and outcomes of hepatectomy for hepatocellular carcinoma.

Venkat R, Hannallah JR, Krouse RS, Maegawa FB.

J Surg Res. 2016 Apr;201(2):498-505. doi: 10.1016/j.jss.2015.08.038. Epub 2015 Aug 28.

PMID:
26409287
14.

Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score.

Donadon M, Costa G, Cimino M, Procopio F, Fabbro DD, Palmisano A, Torzilli G.

World J Surg. 2015 Jan;39(1):237-43. doi: 10.1007/s00268-014-2786-6.

PMID:
25217112
15.

Low postoperative platelet count is associated with negative outcome after liver resection for hepatocellular carcinoma.

Riediger C, Bachmann J, Hapfelmeier A, Friess H, Kleeff J, Mueller MW.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1313-20.

PMID:
25436303
16.

Characteristics and surgical outcome of HCC patients with low platelet count.

Kondo K, Chijiiwa Y, Otani K, Kai M, Ohuchida J, Chijiiwa K.

Hepatogastroenterology. 2012 Oct;59(119):2269-72. doi: 10.5754/hge10649.

PMID:
23435142
17.

Low preoperative platelet counts predict a high mortality after partial hepatectomy in patients with hepatocellular carcinoma.

Kaneko K, Shirai Y, Wakai T, Yokoyama N, Akazawa K, Hatakeyama K.

World J Gastroenterol. 2005 Oct 7;11(37):5888-92.

18.

Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.

Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H; Kagoshima Liver Cancer Study Group.

J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.

PMID:
19300896
19.
20.

Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.

Peng W, Li C, Wen TF, Yan LN, Li B, Wang WT, Yang JY, Xu MQ.

J Surg Res. 2014 Dec;192(2):402-8. doi: 10.1016/j.jss.2014.05.078. Epub 2014 Jun 2.

PMID:
24998425
Items per page

Supplemental Content

Write to the Help Desk